Study of a new catheter system for treating atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new catheter and mapping system designed to treat paroxysmal atrial fibrillation (AF), which is a type of irregular heartbeat that comes and goes. If you have this condition, the study aims to see how well the new system works with a minimally invasive procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with paroxysmal AF (AF that starts and stops on its own or with treatment within 7 days).
- You have had at least 2 episodes of symptomatic AF in the last 6 months, and one episode recorded on an ECG in the last year.
- You are between 18 and 80 years old.
- You are willing and able to attend all follow-up visits for the duration of the study.
- You have not had prior heart procedures like catheter ablation, surgical ablation, or certain valve repairs.
- You are on blood thinners (anticoagulation) for at least 3 weeks before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This study tests a new catheter to treat atrial fibrillation (AF), a heart rhythm problem, in people with symptoms. It aims to see if the treatment is safe and works well for people whose AF comes and goes.
This trial studies a heart procedure using the Affera SpherePVI system to treat paroxysmal (comes and goes) or persistent atrial fibrillation. It’s for people who still have symptoms despite at least one anti-arrhythmia medicine, and who are good candidates for catheter ablation.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study checks how safe and effective a special catheter procedure (SpherePVI) is for treating paroxysmal (comes and goes) or persistent atrial fibrillation. You may be considered if your atrial fibrillation keeps returning and you’ve already tried at least one medication but it didn’t work or you couldn’t tolerate it.
Hear when a new Paroxysmal AF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.